2020, Updates From Phlow™
Source: CNBC Dr. Eric Edwards, CEO of Phlow Corp., joins “Squawk Alley” to discuss the $354 million contract his startup just won to make Covid-19 drugs. Watch Video
2020, Updates From Phlow™
Source: Richmond Times Dispatch A new Richmond-based pharmaceutical manufacturing company has received a $354 million federal contract to help build a strategic, national reserve of essential medications and to make active ingredients for more than a dozen medicines...
2020, Updates From Phlow™
The contract could extend to $812 million over 10 years Source: Fox Business President Trump on Tuesday awarded a $354 million, four-year government contract to a new pharmaceutical company that will manufacture coronavirus drugs in the U.S. The Biomedical Advanced...
2020, Press Releases, Updates From Phlow™
Move Strengthens America’s Supply Chain and Supports COVID-19 Response Source: PR Newswire Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing of America’s...
2020, Updates From Phlow™
Source: Forbes Monday evening, the U.S. government signed a $354 million four-year contract with new pharmaceutical company Phlow Corp. to increase American production of medications that may help treat Covid-19 in a bid to avoid potential supply chain shortages, with...
